Search results for: 'spectrometry machine learning'

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tab...

This research service analyzes the market for proteomics sample preparation solutions within the United States. The United States market was divided into the commodity chemistries and devices, targeted sample extraction or fractionation kits, kits for the affinity capture of high abundant proteins, and pre-spectrometry sample digest and cleanup so...

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

29 Mar 2022  |  North America  |  Frost Radar

Frost Radar™: Global Robotic-assisted Surgical Devices, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

As the healthcare industry continues adjusting to the increasing diagnosis of lifestyle-related diseases and demand for affordable care, effective surgical procedures assisted by robotic devices and a decline in treatment costs look promising. Next-generation surgical robotic technology platforms complement and extend surgeons’ ability to minimize ...

The COVID-19 pandemic and the shift toward value-based care have highlighted the need for more flexible and resilient healthcare systems, creating opportunities for innovative business models. Several challenges, such as personnel burnout, the lack of experienced staff, inflation leading to increased care costs, healthcare accessibility disparities...

The global medical devices market is currently witnessing disruption, led primarily by two key factors: increasing digitization of healthcare delivery and the transition of care settings to locations outside the hospital. There is an increased use of digital technology across the healthcare value chain, and companies operating in data analytics, ar...

Medical devices utilizing single imaging technology have been used for decades. While single imaging technology has its merits, multimodal or combination of different imaging techniques have the potential to improve the diagnostic accuracy of the physician and help achieve better treatment outcomes. With the introduction of whole-body PET-CT and SP...

The convergence of IoT and healthcare, known as the internet of medical things (IoMT), is transforming the healthcare landscape, bringing unprecedented connectivity and convenience. However, the rapid proliferation of IoT devices in healthcare exposes critical data security and cybersecurity risks. This Frost & Sullivan study explores data security...